• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Livongo launches voice-enabled cellular blood pressure monitoring system

Livongo launches voice-enabled cellular blood pressure monitoring system

October 30, 2018 By Sarah Faulkner

Livongo logo - updatedLivongo said today that it launched its Applied Health Signals platform, which seeks to provide meaningful feedback to people living with chronic conditions using novel digital tools and artificial intelligence.

As part of its newly-launched platform, the company developed a voice-enabled, at-home cellular blood pressure monitoring system and said it would provide eligible members with co-pay waivers for medications, in an effort to encourage users to cultivate healthy behaviors.

“It’s exciting to introduce products that change the way people think about and experience chronic conditions. We did that in diabetes, with unlimited free strips, cellular-connected meters, insights and care accessible 24 hours a day anywhere, all of which made it easier for our members to stay healthy. Now we’re doing the same thing for hypertension,” chief product officer Amar Kendale said in prepared remarks. “By delivering blood pressure feedback in a new relevant way and by driving positive behavior change with medication incentives, we are reducing the confusion, complexity and cost of healthcare for our members. We are making healthcare less noisy and paving the way for meaningful and measurable change. That’s what Applied Health Signals is all about.”

Livongo’s next-generation cellular blood pressure monitoring system allows users to interact with Livongo during each use. The company’s Cuff to Cloud program enables people to upload blood pressure readings directly to the Livongo cloud.

Also today, Livongo reported that it inked a partnership with Medisafe to improve medication management for people with chronic conditions. Livongo plans to leverage its relationship with Medisafe to optimize the Applied Health Signals engine over time.

“I could not be more excited to be working with industry leaders and innovators like Medisafe,” Livongo CMO Dr. Jennifer Schneider said.”These partnerships will provide a wealth of new data into our Applied Health Signals engine, and will further our ability to apply actionable, personalized and timely health signals to our members. We are already achieving measurable clinical outcomes, and as more data comes into our engine, our fly wheel begins to spin faster, and we have the ability to affect more behavior change and improve clinical outcomes for more people with chronic conditions.”

Filed Under: Featured, Vascular Tagged With: Livongo

More recent news

  • Boston Scientific continues to make progress on cyberattack recovery
  • Edwards Lifesciences, Medtronic score CMS win for TAVR
  • Stryker still working through cyberattack after-effects, stock down more than 10% this week
  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy